Profilo
Mr. Mark Evans is a Chairman at Obotritia Capital KGaA. Mr. Evans was previously employed as a Non-Independent Non-Executive Director by ReNeuron Group Plc, a Partner by Taube Hodson Stonex Partners LLP, and a Partner by Albemarle Life Sciences LLP.
He received his undergraduate degree from the University of Bristol.
Posizioni attive di Mark Evans
| Società | Posizione | Inizio |
|---|---|---|
Obotritia Capital KGaA
Obotritia Capital KGaA Investment ManagersFinance Obotritia Capital invests in both public and private companies located in Germany. The firm focuses on real estate, financial services and technology. It participates in early stage transactions and also acquires majority interests. | Presidente | - |
Precedenti posizioni note di Mark Evans
| Società | Posizione | Fine |
|---|---|---|
| RENEURON GROUP PLC | Direttore/Membro del Consiglio | 22/03/2022 |
Taube Hodson Stonex Partners LLP
Taube Hodson Stonex Partners LLP Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2016 |
Albemarle Life Sciences LLP
Albemarle Life Sciences LLP MiscellaneousMiscellaneous Operates as a non classified establishment | Corporate Officer/Principal | - |
Formazione di Mark Evans
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
ReNeuron Group Plc
ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
Taube Hodson Stonex Partners LLP
Taube Hodson Stonex Partners LLP Investment ManagersFinance Provides investment advice | Finance |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obotritia Capital KGaA
Obotritia Capital KGaA Investment ManagersFinance Obotritia Capital invests in both public and private companies located in Germany. The firm focuses on real estate, financial services and technology. It participates in early stage transactions and also acquires majority interests. | Finance |
Albemarle Life Sciences LLP
Albemarle Life Sciences LLP MiscellaneousMiscellaneous Operates as a non classified establishment | Miscellaneous |
















